KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Capital Employed (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Return on Capital Employed for 3 consecutive years, with 0.46% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Return on Capital Employed changed N/A year-over-year to 0.46%, compared with a TTM value of 0.46% through Sep 2023, changed N/A, and an annual FY2022 reading of 1.04%, up 44.0% over the prior year.
  • Return on Capital Employed was 0.46% for Q3 2023 at Ginkgo Bioworks Holdings, up from 0.59% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.08% in Q3 2021 and bottomed at 1.28% in Q1 2022.
  • Average Return on Capital Employed over 3 years is 0.66%, with a median of 0.68% recorded in 2023.
  • The sharpest move saw Return on Capital Employed dropped -16bps in 2022, then soared 52bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.93% in 2021, then decreased by -17bps to 1.09% in 2022, then surged by 57bps to 0.46% in 2023.
  • Business Quant data shows Return on Capital Employed for DNA at 0.46% in Q3 2023, 0.59% in Q2 2023, and 0.77% in Q1 2023.